Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinomaResearch in context

Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinomaResearch in context

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies with poor prognosis. Cancer-testis genes (CTGs) have been vigorously pursued as targets for cancer immunotherapy, but the expressive patterns and functional roles of CTGs remain unclear in ESCC. Methods: A s...

Full description

Bibliographic Details
Main Authors:	Jing Xu, Chengxiang Zhu, Yue Yu, Weibing Wu, Jing Cao, Zhihua Li, Juncheng Dai, Cheng Wang, Yu Tang, Quan Zhu, Jun Wang, Wei Wen, Lei Xue, Fuxi Zhen, Jinyuan Liu, Chenjun Huang, Fei Zhao, Yue Zhou, Zhicheng He, Xianglong Pan, Haixing Wei, Yining Zhu, Yaozhou He, Jun Que, Jinghua Luo, Liang Chen, Wei Wang
Format:	Article
Language:	English
Published:	Elsevier 2019-08-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396419304724

Similar Items

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
by: Zhenzhen Luo, et al.
Published: (2021-10-01)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinomaResearch in context
by: Yang Cheng, et al.
Published: (2019-02-01)

Assessment of the Accuracy of Modified Inflation-deflation Methods for Distinguishing the Intersegmental Border
by: Haixing WEI, et al.
Published: (2020-06-01)

Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma
by: Suyu Hao, et al.
Published: (2021-02-01)

Amino acids signatures of distance-related surgical margins of oral squamous cell carcinomaResearch in context
by: Xi-Hu Yang, et al.
Published: (2019-10-01)

Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinomaResearch in context
by: Huan Lu, et al.
Published: (2019-02-01)

Development and validation of a CIMP-associated prognostic model for hepatocellular carcinomaResearch in context
by: Ganxun Li, et al.
Published: (2019-09-01)

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinomaResearch in context
by: Wenliang Tan, et al.
Published: (2019-02-01)

Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinomaResearch in context
by: Haotian Liao, et al.
Published: (2019-03-01)

Comprehensive molecular and immunological characterization of hepatocellular carcinomaResearch in context
by: Shu Shimada, et al.
Published: (2019-02-01)

Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinomaResearch in context
by: Chao Wang, et al.
Published: (2019-01-01)

Pathway-based biomarker identification with crosstalk analysis for robust prognosis prediction in hepatocellular carcinomaResearch in context
by: Botao Fa, et al.
Published: (2019-06-01)

Contemporary update of overall prognosis and nomogram to predict individualized survival for Chinese patients with eyelid sebaceous carcinomaResearch in context
by: Chuandi Zhou, et al.
Published: (2018-10-01)

MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinomaResearch in context
by: Yifan Li, et al.
Published: (2019-06-01)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
by: Zhenjun Yu, et al.
Published: (2021-10-01)

A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia
by: Laixi Bi, et al.
Published: (2018-02-01)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
by: Dexin Shen, et al.
Published: (2021-05-01)

Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinomaResearch in context
by: Zongcheng Yang, et al.
Published: (2019-09-01)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
by: Zhihuai Wang, et al.
Published: (2021-01-01)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
by: Yunhong Tian, et al.
Published: (2018-11-01)

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinomaResearch in context
by: Junyu Long, et al.
Published: (2019-04-01)

Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal CarcinomaResearch in context
by: Jiang-Bo Zhang, et al.
Published: (2018-11-01)

Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells
by: Xin Gao, et al.
Published: (2020-04-01)

CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo
by: Yifei Feng, et al.
Published: (2019-06-01)

Multidimensional study of CDCA family members in gastric carcinoma with prognostic value
by: Peixin Lu, et al.
Published: (2021-05-01)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
by: Yu Shuai, et al.
Published: (2021-03-01)

Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma
by: Xiaoxiong Wang, et al.
Published: (2021-02-01)

Cadmium-Containing Carbonic Anhydrase CDCA1 in Marine Diatom Thalassiosira weissflogii
by: Vincenzo Alterio, et al.
Published: (2015-03-01)

Prognostic Impacts of GPX2, CDCA5, HAS3 and BCAT1 on Urothelial Carcinomas: Data Mining of Transcriptomic Databases
by: I-Wei Chang, et al.
Published: (2015)

SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinomaResearch in context
by: Zhiyong Liu, et al.
Published: (2018-12-01)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
by: Shouyong Liu, et al.
Published: (2021-03-01)

Correction: Corrigendum: Mutations in CDCA7 and HELLS cause immunodeficiency–centromeric instability–facial anomalies syndrome
by: Peter E. Thijssen, et al.
Published: (2016-06-01)

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinomaResearch in context
by: Mengjiao Wu, et al.
Published: (2019-03-01)

Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer
by: Yue Yu, et al.
Published: (2020-01-01)

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
by: Shen Z, et al.
Published: (2018-02-01)

Translobar Phenomenon of Pulmonary Veins and Its Clinical Significance in Lobectomy
by: Wenzheng XU, et al.
Published: (2021-02-01)

Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinomaResearch in context
by: Tianjiao Wang, et al.
Published: (2019-07-01)

CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
by: Yixiang Zhang, et al.
Published: (2020-05-01)

Lateral cortical Cdca7 expression levels are regulated by Pax6 and influence the production of intermediate progenitors
by: Yu-Ting Huang, et al.
Published: (2017-06-01)

Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma
by: Junya Oguma, et al.
Published: (2021-03-01)